Los Angeles Times

Q&A: If you're under 40 you should be hoping for another stock plunge, says pundit Josh Brown

Josh Brown is not your average Wall Street pundit.

Brown is chief executive of Ritholtz Wealth Management, a financial advisory firm in New York, and his blog, the Reformed Broker, is popular reading for those interested in the financial markets. The blog and his Twitter account are often witty, sarcastic, irreverent and peppered with pop culture.

In recently discussing the correlation between stock and bond prices, for instance, Brown wrote that "correlations are like Kristen Stewart - moody and unfaithful," invoking the "Twilight" actress and her tabloid-fodder love life.

Brown, 40, also has a large social-media presence - his @ReformedBroker has more than 1 million followers on Twitter - and he's on CNBC's "Halftime Report."

He's a big proponent of setting up a diversified, long-term portfolio for investors that helps them avoid being rattled by the markets' daily sudden moves. The Times asked Brown about the stock market's wild ride lately. Here's an excerpt:

Q: What's your overall reaction

You're reading a preview, sign up to read more.

More from Los Angeles Times

Los Angeles Times4 min read
Gov. Newsom Orders New California In-person Voting Rules For November Election
SACRAMENTO, Calif. - Gov. Gavin Newsom gave California counties permission on Wednesday to limit their in-person voting operations for the Nov. 3 election as protection against the spread of the coronavirus - but only if they also offer three days of
Los Angeles Times4 min readPolitics
Commentary: Republicans Weaponized 'Amnesty' To Make Undocumented Immigrants Suffer. Let's Take It Back
The scene in the TV ad: a football locker room. A man walks toward the camera, looking us dead in the eye. His name is Tommy Tuberville. He is a Republican, a former football coach, running for the United States Senate in Alabama. He makes three prom
Los Angeles Times3 min readSociety
Michael Hiltzik: Study Concludes Chloroquine Drugs Promoted By Trump Are Worthless Against Coronavirus
The most eagerly anticipated study on the effect of antimalarial drugs - the drugs assiduously promoted by President Trump - on COVID-19 finds that they're worthless against the disease caused by the coronavirus. The results from a trial of 821 non-h